Literature DB >> 17052890

The duration of ERK1/2 activity determines the activation of c-Fos and Fra-1 and the composition and quantitative transcriptional output of AP-1.

Claire J Chalmers1, Rebecca Gilley, Helen N March, Kathryn Balmanno, Simon J Cook.   

Abstract

The duration of ERK1/2 activation influences the nature of the biological response to agonist. Members of the AP-1 transcription factor family are well known targets of the ERK1/2 pathway and are expressed in a temporally coordinated fashion during cell cycle re-entry. In CCl39 fibroblasts, sustained ERK1/2 activation is required for the expression of Fra-1, Fra-2, c-Jun and JunB, whereas expression of c-Fos is still strongly induced even in response to transient ERK activation. However, the significance of this pattern of expression for AP-1 activity has not been addressed. Here we show that growth factor stimulated activation of the C-terminal c-Fos transactivation domain (TAD) serves as a sensor for ERK1/2 signal duration whereas the c-JunTAD is not responsive to growth factors. In addition, sustained ERK1/2 activation determines the duration of increases in AP-1 DNA binding complexes as well as their qualitative make up. Finally, this is reflected in both the duration and quantitative transcriptional output of stably integrated AP-1 reporter constructs, indicating that AP-1 activity is finely tuned to ERK1/2 signal duration. These results provide new insights into the importance of ERK1/2 signal duration in the regulation of AP-1 and provide an explanation for how differences in signal duration can lead to both quantitative and qualitative changes in gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17052890     DOI: 10.1016/j.cellsig.2006.09.001

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  30 in total

1.  Negative feedback regulation of Raf/MEK/ERK cascade after sublethal cerebral ischemia in the rat hippocampus.

Authors:  Q Cao; M Qian; X F Wang; B Wang; H W Wu; X J Zhu; Ying Wei Wang; J Guo
Journal:  Neurochem Res       Date:  2010-10-15       Impact factor: 3.996

2.  ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Xiaojuan Li; Shumin Du; Denis Avey; Yuqing Li; Fanxiu Zhu; Ersheng Kuang
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

3.  Heterodimerization with different Jun proteins controls c-Fos intranuclear dynamics and distribution.

Authors:  Cécile E Malnou; Frédérique Brockly; Cyril Favard; Gabriel Moquet-Torcy; Marc Piechaczyk; Isabelle Jariel-Encontre
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 4.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

5.  The dynamics of signaling as a pharmacological target.

Authors:  Marcelo Behar; Derren Barken; Shannon L Werner; Alexander Hoffmann
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

Review 6.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

7.  Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases.

Authors:  Jimmy Delaney; Roselynn Chiarello; David Villar; Umadevi Kandalam; Ana Maria Castejon; Michelle A Clark
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

8.  Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells.

Authors:  Eileen Looby; Mohamed M M Abdel-Latif; Veronica Athié-Morales; Shane Duggan; Aideen Long; Dermot Kelleher
Journal:  BMC Cancer       Date:  2009-06-17       Impact factor: 4.430

9.  Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells.

Authors:  Yuko Saeki; Takaho Endo; Kaori Ide; Takeshi Nagashima; Noriko Yumoto; Tetsuro Toyoda; Harukazu Suzuki; Yoshihide Hayashizaki; Yoshiyuki Sakaki; Mariko Okada-Hatakeyama
Journal:  BMC Genomics       Date:  2009-11-20       Impact factor: 3.969

10.  A selective eradication of human nonhereditary breast cancer cells by phenanthridine-derived polyADP-ribose polymerase inhibitors.

Authors:  Dana Inbar-Rozensal; Asher Castiel; Leonid Visochek; David Castel; Françoise Dantzer; Shai Izraeli; Malka Cohen-Armon
Journal:  Breast Cancer Res       Date:  2009-11-09       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.